Drugs used in diabetes treat diabetes mellitus by lowering the glucose level in the blood.
The report focuses on the Diabetes Drug market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Diabetes Drug market.
Major Players in the Diabetes Drug market are:
Novartis, Astellas
NovoNordisk.
Abbott Laboratories.
Wockhardt.
Boehringer Ingelheim.
Sanofi.
SEDICO.
AstraZeneca.
Merck.
Eli Lilly.
Johnson & Johnson.
Pfizer.
Bristol Myers Squibb.
Mylan.
Biocon.
Julphar.
GlaxoSmithKline PLC.
Exir.
On the basis of types, the Diabetes Drug market is primarily split into:
Sulphonylureas
Biguanides
Meglitinides
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
SGLT-2 Inhibitors
On the basis of applications, the market covers:
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Diabetes Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Diabetes Drug Market Overview
1.1 Product Overview and Scope of Diabetes Drug Market
1.2 Diabetes Drug Market Segment by Type
1.2.1 Global Diabetes Drug Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Diabetes Drug Market Segment by Application
1.3.1 Diabetes Drug Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Diabetes Drug Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Diabetes Drug (2017-2029)
1.5.1 Global Diabetes Drug Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Diabetes Drug Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Diabetes Drug Industry
1.7 Impact of Carbon Neutrality on the Diabetes Drug Industry
2 Diabetes Drug Market Upstream and Downstream Analysis
2.1 Diabetes Drug Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Diabetes Drug Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Novartis, Astellas
3.1.1 Novartis, Astellas Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Diabetes Drug Market Performance (2017-2022)
3.1.4 Business Overview
3.2 NovoNordisk.
3.2.1 NovoNordisk. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Diabetes Drug Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Abbott Laboratories.
3.3.1 Abbott Laboratories. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Diabetes Drug Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Wockhardt.
3.4.1 Wockhardt. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Diabetes Drug Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Boehringer Ingelheim.
3.5.1 Boehringer Ingelheim. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Diabetes Drug Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Sanofi.
3.6.1 Sanofi. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Diabetes Drug Market Performance (2017-2022)
3.6.4 Business Overview
3.7 SEDICO.
3.7.1 SEDICO. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Diabetes Drug Market Performance (2017-2022)
3.7.4 Business Overview
3.8 AstraZeneca.
3.8.1 AstraZeneca. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Diabetes Drug Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Merck.
3.9.1 Merck. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Diabetes Drug Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Eli Lilly.
3.10.1 Eli Lilly. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Diabetes Drug Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Johnson & Johnson.
3.11.1 Johnson & Johnson. Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Diabetes Drug Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Pfizer.
3.12.1 Pfizer. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Diabetes Drug Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Bristol Myers Squibb.
3.13.1 Bristol Myers Squibb. Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Diabetes Drug Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Mylan.
3.14.1 Mylan. Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Diabetes Drug Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Biocon.
3.15.1 Biocon. Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Diabetes Drug Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Julphar.
3.16.1 Julphar. Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Diabetes Drug Market Performance (2017-2022)
3.16.4 Business Overview
3.17 GlaxoSmithKline PLC.
3.17.1 GlaxoSmithKline PLC. Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Diabetes Drug Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Exir.
3.18.1 Exir. Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Diabetes Drug Market Performance (2017-2022)
3.18.4 Business Overview
4 Global Diabetes Drug Market Landscape by Player
4.1 Global Diabetes Drug Sales and Share by Player (2017-2022)
4.2 Global Diabetes Drug Revenue and Market Share by Player (2017-2022)
4.3 Global Diabetes Drug Average Price by Player (2017-2022)
4.4 Global Diabetes Drug Gross Margin by Player (2017-2022)
4.5 Diabetes Drug Market Competitive Situation and Trends
4.5.1 Diabetes Drug Market Concentration Rate
4.5.2 Diabetes Drug Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Diabetes Drug Sales, Revenue, Price Trend by Type
5.1 Global Diabetes Drug Sales and Market Share by Type (2017-2022)
5.2 Global Diabetes Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Diabetes Drug Price by Type (2017-2022)
5.4 Global Diabetes Drug Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Diabetes Drug Sales, Revenue and Growth Rate of Sulphonylureas (2017-2022)
5.4.2 Global Diabetes Drug Sales, Revenue and Growth Rate of Biguanides (2017-2022)
5.4.3 Global Diabetes Drug Sales, Revenue and Growth Rate of Meglitinides (2017-2022)
5.4.4 Global Diabetes Drug Sales, Revenue and Growth Rate of Thiazolidinediones (2017-2022)
5.4.5 Global Diabetes Drug Sales, Revenue and Growth Rate of Alpha-glucosidase Inhibitors (2017-2022)
5.4.6 Global Diabetes Drug Sales, Revenue and Growth Rate of DPP-4 Inhibitors (2017-2022)
5.4.7 Global Diabetes Drug Sales, Revenue and Growth Rate of SGLT-2 Inhibitors (2017-2022)
6 Global Diabetes Drug Market Analysis by Application
6.1 Global Diabetes Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Diabetes Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Diabetes Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Diabetes Drug Consumption and Growth Rate of Type 1 Diabetes (2017-2022)
6.3.2 Global Diabetes Drug Consumption and Growth Rate of Type 2 Diabetes (2017-2022)
6.3.3 Global Diabetes Drug Consumption and Growth Rate of Gestational Diabetes (2017-2022)
6.3.4 Global Diabetes Drug Consumption and Growth Rate of Impaired Glucose Tolerance and Impaired Fasting Glycaemia (2017-2022)
7 Global Diabetes Drug Sales and Revenue Region Wise (2017-2022)
7.1 Global Diabetes Drug Sales and Market Share, Region Wise (2017-2022)
7.2 Global Diabetes Drug Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Diabetes Drug Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Diabetes Drug Market Forecast (2022-2029)
8.1 Global Diabetes Drug Sales, Revenue Forecast (2022-2029)
8.1.1 Global Diabetes Drug Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Diabetes Drug Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Diabetes Drug Price and Trend Forecast (2022-2029)
8.2 Global Diabetes Drug Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.2.3 China Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.2.5 India Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Diabetes Drug Sales and Revenue Forecast (2022-2029)
8.3 Global Diabetes Drug Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Diabetes Drug Revenue and Growth Rate of Sulphonylureas (2022-2029)
8.3.2 Global Diabetes Drug Revenue and Growth Rate of Biguanides (2022-2029)
8.3.3 Global Diabetes Drug Revenue and Growth Rate of Meglitinides (2022-2029)
8.3.4 Global Diabetes Drug Revenue and Growth Rate of Thiazolidinediones (2022-2029)
8.3.5 Global Diabetes Drug Revenue and Growth Rate of Alpha-glucosidase Inhibitors (2022-2029)
8.3.6 Global Diabetes Drug Revenue and Growth Rate of DPP-4 Inhibitors (2022-2029)
8.3.7 Global Diabetes Drug Revenue and Growth Rate of SGLT-2 Inhibitors (2022-2029)
8.4 Global Diabetes Drug Consumption Forecast by Application (2022-2029)
8.4.1 Global Diabetes Drug Consumption Value and Growth Rate of Type 1 Diabetes (2022-2029)
8.4.2 Global Diabetes Drug Consumption Value and Growth Rate of Type 2 Diabetes (2022-2029)
8.4.3 Global Diabetes Drug Consumption Value and Growth Rate of Gestational Diabetes (2022-2029)
8.4.4 Global Diabetes Drug Consumption Value and Growth Rate of Impaired Glucose Tolerance and Impaired Fasting Glycaemia (2022-2029)
8.5 Diabetes Drug Market Forecast Under COVID-19
9 Industry Outlook
9.1 Diabetes Drug Market Drivers Analysis
9.2 Diabetes Drug Market Restraints and Challenges
9.3 Diabetes Drug Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Diabetes Drug Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Diabetes Drug Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Diabetes Drug Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Metformin Hydrochloride Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystall......
Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 112
Market Overview of Global Antidiabetic Sulphonylureas market:
According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
Global Insulin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
Global Insulin API Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period.
The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
Global Glucagon Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Acarbose Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period.
The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Insulin Glargine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 77
According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
Global Liraglutide Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 103
According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period.
The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
